Mental DailyMental Daily
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Aa
Mental Daily
Aa
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • Opinion
Search
  • Clinical
  • Health
  • I/O
  • Cybernetic
  • Social
  • More
    • Opinion
    • My Bookmarks
Follow US
  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store
© 2022 - Mental Daily. All Rights Reserved.
Clinical

MDMA, or ecstasy, may be efficacious in reducing symptoms of PTSD

Staff Writer
Staff Writer 2 years ago
Updated 2021/05/18 at 12:03 AM
Share
SHARE

Given that the efficacy of serotonin-reuptake inhibitors for post-traumatic stress disorder (PTSD) is limited, a group of researchers explored the use of MDMA.

Granted an FDA Breakthrough Therapy designation for its purported potential to effectively treat symptoms of mental illness, a study published in Nature Medicine considers the use of ecstasy for treating PTSD.

MDMA purportedly functions through its targeting of the serotonin system, possibly alleviating a host of symptoms, like severe anxiety, panic attacks, insomnia, nightmares, and flashbacks.

As part of the phase 3 randomized clinical trial, 90 participants received MDMA for a span of 18 weeks, to test for its efficacy against PTSD.

Researchers tracked for adverse reactions throughout the entire duration of the study.

According to the findings: “These data indicate that, compared with manualized therapy with inactive placebo, MDMA-assisted therapy is highly efficacious in individuals with severe PTSD, and treatment is safe and well-tolerated, even in those with comorbidities.”

“We conclude that MDMA-assisted therapy represents a potential breakthrough treatment that merits expedited clinical evaluation,” author Jennifer Mitchel and her colleagues concluded in their findings.

Photo: iStock

You Might Also Like

Researchers have uncovered hints as to why immune cells appear to cause brain damage

Researchers use AI to generate video from brain activity

People are more creative upon awakening from the earliest stage of sleep: new study

Memory loss associated with Alzheimer’s may be mitigated through deep sleep

New research finds specific strains of Desulfovibrio bacteria may cause Parkinson’s disease

TAGGED: drugs, mdma, ptsd
Staff Writer May 17, 2021
Share this Article
Facebook Twitter Whatsapp Whatsapp Email Print
Previous Article Study of female inmates uncover drastic head injuries linked to prolonged abuse
Next Article Online-based cognitive behavioral therapy cost-effective and therapeutic for social anxiety

Recommended

Clinical

Researchers have uncovered hints as to why immune cells appear to cause brain damage

1 Min Read
Clinical

Researchers use AI to generate video from brain activity

2 Min Read
Clinical

People are more creative upon awakening from the earliest stage of sleep: new study

1 Min Read
Clinical

Memory loss associated with Alzheimer’s may be mitigated through deep sleep

2 Min Read
//

We are a trusted online source for research news and resources on all aspects of the mind and human behavior.

Verticals

  • Clinical
  • Health
  • Social
  • I/O
  • Opinion

Social

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Links

  • About
  • Contact
  • The Editor
  • Terms & Conditions
  • Privacy Policy
Follow US

© 2022 Mental Daily. All Rights Reserved.

  • Twitter
  • Facebook
  • Instagram
  • Inc. Profile
  • Google Play Store

Removed from reading list

Undo
Welcome Back!

Sign in to your account

Lost your password?